Caspofungin Market by Indication (Candidiasis, and Thrush); By Distribution channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies); By Geography (North America, Asia-Pacific, Europe, South America, and RoW), Industry Trends, Estimation & Forecast, 2018 – 2026

Market Overview

The Global Caspofungin market is expected to reach $491.8 million by 2026, growing at a CAGR of 0.21% during the forecast period. Caspofungin is used to treat a range of fungal infections. It is regularly used in patients who cannot use or do not respond to other anti-fungal medications (such as itraconazole and amphotericin).

Market Dynamics

Increase in incidence of candidaemia in ICUs across the world is the major factor driving the growth of the global caspofungin market. However, side effects of caspofungin such as nausea, vomiting, diarrhea, or headache may occur if the medicine is not taken in a proper manner, this factor may limit the growth of the market. Moreover, increase in incidence of invasive candidiasis is expected to generate numerous growth prospects for the market in the forthcoming years.

Market Segmentation

The global caspofungin market is segmented based on indication, distribution channel, and geography. The indication segment includes candidiasis, and thrush. Distribution channel segment can be divided into hospital pharmacies, retail pharmacies, and online pharmacies. Furthermore, geographical coverage has been offered for each of the major regions including North America, Asia-Pacific, Europe, RoW, and South America.

Scope of the Global Caspofungin Market

By Indication

• Candidiasis
• Thrush

By Distribution channel

• Hospital pharmacies
• Retail pharmacies
• Online Pharmacies

By Geography

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Korea
  • Rest of APAC
• South America
  • Brazil
  • Rest of South America
• Rest of the World
  • Middle East
  • Africa

TABLE OF CONTENTS

Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Market Scope

Chapter 2 Research Methodology
2.1 Primary Research
2.2 Research Methodology
2.3 Assumptions & Exclusions
2.4 Secondary Data Sources

Chapter 3 Market Overview
3.1 Report Segmentation & Scope
3.2 Key Market Trends
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunities
3.3 Porter’s Five Forces Analysis
3.4 Market Share Analysis

Chapter 4 Global Caspofungin Market by Indication: Market Size and Forecast, 2018 – 2026
4.1 Introduction
4.1.1 Market Size and Forecast
4.2 Candidiasis
4.2.1 Market Size and Forecast
4.3 Thrush
4.3.1 Market Size and Forecast

Chapter 5 Global Caspofungin Market by Distribution Channel: Market Size and Forecast, 2018 – 2026
5.1 Introduction
5.1.1 Market Size and Forecast
5.2 Hospital Pharmacies
5.2.1 Market Size and Forecast
5.3 Retail Pharmacies
5.3.1 Market Size and Forecast
5.4 Online Pharmacies
5.4.1 Market Size and Forecast

Chapter 6 Global Caspofungin Market by Geography: Market Size and Forecast, 2018 – 2026
6.1 Introduction
6.1.1 Market Size and Forecast
6.2 North America
6.2.1 North America Market Size & Forecast, By Country
6.2.2 North America Market Size & Forecast, By Indication
6.2.3 North America Market Size & Forecast, By Distribution Channel
6.2.4 U.S.
6.2.4.1 Market Size and Forecast
6.2.5 Canada
6.2.5.1 Market Size and Forecast
6.2.6 Mexico
6.2.6.1 Market Size and Forecast
6.3 Europe
6.3.1 Europe Market Size and Forecast, By Country
6.3.2 Europe Market Size and Forecast, By Indication
6.3.3 Europe Market Size and Forecast, By Distribution Channel
6.3.4 UK
6.3.4.1 Market Size and Forecast
6.3.5 Germany
6.3.5.1 Market Size and Forecast
6.3.6 France
6.3.6.1 Market Size and Forecast
6.3.7 Italy
6.3.7.1 Market Size and Forecast
6.3.8 Spain
6.3.8.1 Market Size and Forecast
6.3.9 Rest of Europe
6.3.9.1 Market Size and Forecast
6.4 Asia-Pacific
6.4.1 Asia-Pacific Market Size and Forecast, By Country
6.4.2 Asia-Pacific Market Size and Forecast, By Indication
6.4.3 Asia-Pacific Market Size and Forecast, By Distribution Channel
6.4.4 India
6.4.4.1 Market Size and Forecast
6.4.5 China
6.4.5.1 Market Size and Forecast
6.4.6 Australia
6.4.6.1 Market Size and Forecast
6.4.7 Japan
6.4.7.1 Market Size and Forecast
6.4.8 South Korea
6.4.8.1 Market Size and Forecast
6.4.9 Rest of Asia-Pacific
6.4.9.1 Market Size and Forecast
6.5 South America
6.5.1 South America Market Size and Forecast, By Country
6.5.2 South America Market Size and Forecast, By Indication
6.5.3 South America Market Size and Forecast, By Distribution Channel
6.5.4 Brazil
6.5.4.1 Market Size and Forecast
6.5.5 Rest of South America
6.5.5.1 Market Size and Forecast
6.6 RoW
6.6.1 RoW Market Size and Forecast, by Country
6.6.2 RoW Market Size and Forecast, by Indication
6.6.3 RoW Market Size and Forecast, by Distribution Channel
6.6.4 Middle East
6.6.4.1 Market Size and Forecast
6.6.5 Africa
6.6.5.1 Market Size and Forecast

Chapter 7 Company Profiles
7.1 Fresenius SE & Co. KGaA
7.2 Gland Pharma Limited
7.3 Merck & Co., Inc.
7.4 Mylan N.V
7.5 Teva Pharmaceutical Industries Ltd.
7.6 Xellia Pharmaceuticals

Caspofungin Market Key Players

• Fresenius SE & Co. KGaA
• Gland Pharma Limited
• Merck & Co., Inc.
• Mylan N.V
• Teva Pharmaceutical Industries Ltd.
• Xellia Pharmaceuticals